Galil Medical, a BTG International group company
Galil Medical | Cryotherapy Solutions | Ablation of solid tumor cancers | Nerve Ablation for pain management | Cryoablation | Cryosurgery
About Galil Medical, a BTG International group company
Galil Medical, now part of the BTG International group, operates as a medical device company with a specialized focus on cryoablation technology for treating cancerous and benign tumors. Founded in Israel in 1997, the company was established as a partnership between Elron and RDC, the commercialization arm of Rafael Advanced Defense Systems. Its foundational technology for freezing tumors was reportedly based on Rafael's missile cooling systems.
The company's business is centered on the development, manufacturing, and sale of cryoablation systems and disposable needles. These products are sold to healthcare providers, specifically targeting physician specialties like interventional radiology, urology, and oncology. The technology operates on the Joule-Thomson effect, using compressed argon gas to create extremely low temperatures at the tip of a needle. This process forms an "ice ball" that engulfs and destroys diseased tissue. Galil Medical offers a variety of needles designed to create freeze zones that match different tumor sizes and shapes, thereby minimizing damage to adjacent healthy tissue.
Galil Medical's product portfolio includes systems like the Visual-ICE and ICEfx Cryoablation Systems, along with a range of cryoablation needles such as the IcePearl and IceFORCE series. A key feature of its newer technology is a helium-free active thaw capability, which can reduce procedural costs for hospitals. The company's products have received FDA clearance for use in numerous applications, including the treatment of kidney, prostate, and liver cancers, as well as for use in dermatology, neurology, and gynecology. Before its acquisition, Galil Medical had established a global presence with offices in Arden Hills, Minnesota, and Yokneam, Israel. In May 2016, the company was acquired by the UK-based healthcare company BTG plc for an initial sum of $84.5 million, with up to an additional $25.5 million in milestone payments. At the time of the acquisition, Galil Medical employed approximately 100 people and had global sales of around $22 million in the preceding year.
Source: Dealroom company dataNews
Open roles
Galil Medical, a BTG International group company in the Arden Hills ecosystem
The Galil Medical, a BTG International group company office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Thomas McNerney & Partners
The Vertical Group
Investor Growth Capital
Armentum Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Galil Medical, a BTG International group company on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Galil Medical, a BTG International group company on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


